维普中文期刊产品整合服务
14篇 您的检索式:作者名="JIANFENG T"
    题名 作者 年代 出处 被引量
1Knowledge stock, exploration, and innovation: research on the United States electromedical device industry显示文摘WU Jianfeng SHANLEY M T 2009Journal of Business Research2009,62,4:1
2The Use of Clustering Techniques for Language Modeling-Applica- tion to Asian Language显示文摘Gao Jianfeng Goodman J T Miao Jiangbo 2001Computational Linguistics and Chinese Language Processing2001,6,1:1
3Fabrication of low-shrinkage porous silicon nitride ceramics by addition of a small amount of carbon 显示文摘YANG Jianfeng ZHANG Guojun OHJI T 2001Journal of the American Ceramic Society2001,84,7:1
4Characterization of 35 novel microsatellite DNA markers from the duck (Anas platyrhynchos) genome and cross-amplification in other birds 显示文摘YINHUA H JIANFENG T XUEBO C 2005Genet Sel Evol2005,37,:1
5Synchrosqueezed wavelet transforms:an empirical mode decomposition- like tool显示文摘Daubechies I Lu Jianfeng Wu H T 2011Applied and Computational Harmonic Analysis2011,30,2:1
6Clinical validity and utility of genetic risk scores in prostate cancer显示文摘电流与前列腺癌症(PCa ) 有关发出临床的照顾(例如,过去屏蔽, nonaggressive PCa 的在诊断上,和在处理上) 为能与家庭历史(FH ) 被相结合成层的风险评价工具的电话在在一般人口的人之中的疾病风险。自从 2007,染色体宽的协会研究(GWAS ) 识别了与 PCa 危险性联系的超过 100 SNP。在这评论,我们讨论(1 ) 这些 PCa 联系风险的 SNP 的有效性,个别地并且一起;(2 ) 各种各样的方法使用了测量多重 SNP 的累积效果,包括基因风险分数(GRS ) ;(3 ) SNP 的足够的数字为风险评价需要;(4 ) 风险的重新分类基于发展 SNP 的数字过去常计算基因风险,(5 ) 从各种各样的种族组为人冒险评价,并且(6 ) 基因风险评价的临床的用途。在结论,对日期支持可得到的数据在在人与或没有 FH 之中的风险评价的 PCa 联系风险的 SNP 和 GRS 的临床的有效性。PCa 联系风险的 SNP 没为诊断使用被打算;更确切地说,他们应该被使用象 FH 的一样的方法。联合 GRS 和 FH 罐头显著地改进风险评价的表演。改进风险评价可以在测试的指向的 PCa 有重要临床的用途。然而,临床的试用着急地被需要由病人和医生评估这个临床的实用程序以及 GRS 的接受。Brian T Helfand James Kearns Carly Conran Jianfeng Xu 2016Asian Journal of Andrology2016,18,4:1
7Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases显示文摘基因风险分数(GRS ) 基于疾病联系风险的单个核苷酸多型性(SNP ) 是能被用来除了家庭历史为特定的疾病提供继承信息的一个增进知识的工具。然而,当计算 GRS 时,在一个特定的种族组被含有的 SNP 是否仅仅应该被使用,仍然是未知的。学习是为在 1338 个病人之中预言前列腺癌症(PCa ) 比较赛跑特定的 GRS 和 nonrace 特定的 GRS 的表演的这的目的在上海经历了前列腺活体检视,中国。赛跑特定的 GRS 与七 PCa 联系风险的 SNP 被计算在东方亚洲人(GRS7 ) 含有,并且 nonrace 特定的 GRS 基于 76 PCa 联系风险的 SNP 是计算的在至少一个种族组(GRS76 ) 含有。分别地, GRS7 和 GRS76 的工具在学习人口是 1.19 和 1.85。更高的 GRS7 和 GRS76 在 univariate 和 multivariate 分析是为 PCa 和高级 PCa 的独立预言者。GRS7 为区别 PCa (0.602 对 0.573 ) 和高级 PCa (0.603 对 0.575 ) 比 GRS76 在操作接收装置的曲线(AUC ) 下面有一个更好的区域但是没到达统计意义。有的 GRS7 一更好(多达 13% 在不同截止) 积极预兆的价值(PPV ) 比 GRS76。在结论,赛跑特定的 GRS 是更柔韧的并且当比用没被显示与东方亚洲人被联系的 SNP 计算的 GRS 在东方亚洲人预言 PCa 时,有更好的表演。Rong Na Dingwei Ye Jun Qi Fang Liu Xiaoling Lin Brian T Helfand Charles B Brendler Carly Conran Jian Gong Yishuo Wu Xu Gao Yaqing Chen S Lilly Zheng Zengnan Mo Qiang Ding Yinghao Sun Jianfeng Xu 2016Asian Journal of Andrology2016,18,4:1
8Knowledge stock, exploration and innovation: Research on the United States electro-medical device industry 显示文摘Wu Jianfeng Shanley T M 2009Journal of Business Research2009,62,4:1
9Characterization of 35 novel microsatellite DNA markers from the duck (Anas platyrhynchos) genome and cross-amplification in other birds显示文摘Yinhua H Jianfeng T Xuebo C 2005Genet Sel Evol2005,37,:1
10Knowledge stock, exploration, and innovation: research on the united states electrometrical device industry显示文摘JIANFENG WU MARK T SHANLEY 2009Journal of Business Re- search2009,,62:1
11“Subduction Initiation” for the Genesis of Podiform Chromite Deposits显示文摘There is a diversity of unusual minerals and mineral inclusions associated with podiform chromitites.The presence of these minerals suggests that grains of amphibolite(plagioclase,amphibole and zircon)and eclogite(coesite,kyanite and garnet)were present in the magmas from which chromite crystallized.ZHOU Meifu ROBINSON Paul T SU Benxun GAO Jianfeng LI Jianwei YANG Jingsui MALPAS John 2015Acta Geologica Sinica(English Edition)2015,89,A02:1
12Knowledge stock,explora- tion and innovation:research on the United States electro- medical device industry显示文摘Wu Jianfeng SHANLEY M T 2009Journal of business research2009,62,4:1
13Performance of wavelet packet-division multiplexing in impulsive and Gaussian noise 显示文摘Wong K M Wu jianfeng Davidson T N 2000IEEE Trans on Communications2000,48,7:1
14Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort显示文摘Inflammatory bowel disease(IBD),including Crohn’s disease(CD)and ulcerative colitis(UC),is a chronic inflammatory disease of the digestive tract with increasing prevalence globally.Although venous thromboembolism(VTE)is a major complication in IBD patients,it is often underappreciated with limited tools for risk stratification.AIM To estimate the proportion of VTE among IBD patients and assess genetic risk factors(monogenic and polygenic)for VTE.METHODS Incident VTE was followed for 8465 IBD patients in the UK Biobank(UKB).The associations of VTE with F5 factor V leiden(FVL)mutation,F2 G20210A prothrombin gene mutation(PGM),and polygenic score(PGS003332)were tested using Cox hazards regression analysis,adjusting for age at IBD diagnosis,gender,and genetic background(top 10 principal components).The performance of genetic risk factors for discriminating VTE diagnosis was estimated using the area under the receiver operating characteristic curve(AUC).RESULTS The overall proportion of incident VTE was 4.70%in IBD patients and was similar for CD(4.46%),UC(4.49%),and unclassified(6.42%),and comparable to that of cancer patients(4.66%)who are well-known at increased risk for VTE.Mutation carriers of F5/F2 had a significantly increased risk for VTE compared to non-mutation carriers,hazard ratio(HR)was 1.94,95%confidence interval(CI):1.42-2.65.In contrast,patients with the top PGS decile had a considerably higher risk for VTE compared to those with intermediate scores(middle 8 deciles),HR was 2.06(95%CI:1.57-2.71).The AUC for differentiating VTE diagnosis was 0.64(95%CI:0.61-0.67),0.68(95%CI:0.66-0.71),and 0.69(95%CI:0.66-0.71),respectively,for F5/F2 mutation carriers,PGS,and combined.CONCLUSION Similar to cancer patients,VTE complications are common in IBD patients.PGS provides more informative risk information than F5/F2 mutations(FVL and PGM)for personalized thromboprophylaxis.Andrew S Rifkin Zhuqing Shi Jun Wei Siqun Lilly Zheng Brian T Helfand Jonathan S Cordova Vincent F Biank Alfonso J Tafur Omar Khan Jianfeng Xu 2023World Journal of Gastroenterology2023,29,39:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费